Knowledge Hub

Global Microbiome Therapeutics Market Size, Status and Forecast 2022

Press Release   •   Jan 06, 2017 07:45 EST has recently announced the addition of a market study “ Global Microbiome Therapeutics Market Size, Status and Forecast 2022 ”, is a comparative analysis of the global market.


Production, means the output of Microbiome Therapeutics

Revenue, means the sales value of Microbiome Therapeutics

This report studies the global Microbiome Therapeutics market, analyzes and researches the Microbiome Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

MicroBiome Therapeutics LLC

Seres Therapeutics

Enterome Bioscience

MaaT Pharma

Rebiotix, Inc

Ritter Pharmaceuticals

Second Genome


Market segment by Regions/Countries, this report covers

United States





Southeast Asia

Market segment by Type, Microbiome Therapeutics can be split into

Fecal Microbial Transplant


Download The sample Copy Of This Report:

Market segment by Application, Microbiome Therapeutics can be split into

Clostridium difficle infection

Crohns disease




Table Of Content

Global Microbiome Therapeutics Market Size, Status and Forecast 2022

1 Industry Overview of Microbiome Therapeutics

1.1 Microbiome Therapeutics Market Overview

1.1.1 Microbiome Therapeutics Product Scope

1.1.2 Market Status and Outlook

1.2 Global Microbiome Therapeutics Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Microbiome Therapeutics Market by Type

1.3.1 Fecal Microbial Transplant

1.3.2 Drugs

1.4 Microbiome Therapeutics Market by End Users/Application

1.4.1 Clostridium difficle infection

1.4.2 Crohns disease

1.4.3 IBD

1.4.4 Diabetes

1.4.5 Others

2 Global Microbiome Therapeutics Competition Analysis by Players

2.1 Microbiome Therapeutics Market Size (Value) by Players (2015-2016)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 MicroBiome Therapeutics LLC

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.1.5 Recent Developments

3.2 Seres Therapeutics

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.2.5 Recent Developments

3.3 Enterome Bioscience

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.3.5 Recent Developments

3.4 MaaT Pharma

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.4.5 Recent Developments

3.5 Rebiotix, Inc

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.5.5 Recent Developments

3.6 Ritter Pharmaceuticals

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.6.5 Recent Developments

3.7 Second Genome

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.7.5 Recent Developments

3.8 OpenBiome

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Microbiome Therapeutics Revenue (Value) (2011-2016)

3.8.5 Recent Developments